Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03538587 : Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children With High Grade Brain Tumors and Their Caregivers
PhaseN/A
AgesMin: 5 Years Max: 99 Years
Eligibility
- INCLUSION CRITERIA FOR CHILDREN:

- Patients must have a diagnosis of a high-grade brain tumor with active
disease,confirmed by medical record review. Note: A diagnosis of DIPG does not need a
biopsy to confirm high-grade.

- Patients with active disease

- Age greater than or equal to 5 years and less than or equal to 17 years of age

- Must be able to speak and understand English.

- Must have a parent or adult primary caregiver willing to participate in the study.

- Ability of Legally Authorized Representative to understand and the willing to sign a
written informed consent document.

- Must have access to a computer/mobile device and the internet.

EXCLUSION CRITERIA FOR CHILDREN:

- Patients will be excluded if there is evidence of pre-morbid severe cognitive or
psychiatric disability that would impair their capacity for participation or
completion of evaluations in the judgment of the investigators.

- Evidence of disease progression at the time of referral to this study to the extent
that it would impede participation or completion of evaluations as determined by the
medical advisory investigator in conjuction with the study PI/adjunct PI.

- Patients with treatment-related sequelae so severe that they would be unable to
complete the study-related evaluations or intervention (e.g., treatment toxicity) as
determined by the medical advisory investigator in conjuction with the study
PI/adjunct PI.

INCLUSION CRITERIA FOR PARENT OR ADULT PRIMARY CAREGIVER:

- Must be a parent or primary caregiver of a child (age 5 to 17 years of age) who has
been diagnosed with a high-grade brain tumor.

- Must have a child willing to participate in the study

- Must be able to speak and understand English.

- Ability of subject to understand and the willing to sign a written informed consent
document.

- Must have access to a computer/mobile device and the internet.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03538587      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740